Article info

Download PDFPDF

Correspondence on ‘Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement’
Free

Authors

  1. Correspondence to Dr Ankur Kumar Jindal, Allergy Immunology Unit, Department of Pediatrics, Post Graduate Institute of Medical Education and Research, Chandigarh, India; ankurjindal11{at}gmail.com
View Full Text

Citation

Banday AZ, Jindal AK, Singh S
Correspondence on ‘Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement’

Publication history

  • Received January 12, 2021
  • Accepted January 15, 2021
  • First published March 4, 2021.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.